This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH, VA, USDA, and EPA for products, services, and maintenance for their specialized laboratory instruments. This award does not have a set-aside designation, and the ultimate completion date is July 31, 2024.
Generated 8/2/24, 9:29 AM